Literature DB >> 26460355

Decade in review--polycystic kidney disease: Slowing progression of autosomal dominant polycystic kidney disease.

Robert W Schrier1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26460355     DOI： 10.1038/nrneph.2015.164

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Blood pressure in early autosomal dominant polycystic kidney disease.

Authors:  Robert W Schrier; Kaleab Z Abebe; Ronald D Perrone; Vicente E Torres; William E Braun; Theodore I Steinman; Franz T Winklhofer; Godela Brosnahan; Peter G Czarnecki; Marie C Hogan; Dana C Miskulin; Frederic F Rahbari-Oskoui; Jared J Grantham; Peter C Harris; Michael F Flessner; Kyongtae T Bae; Charity G Moore; Arlene B Chapman
Journal:  N Engl J Med       Date:  2014-11-15       Impact factor: 91.245

2.  Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.

Authors:  Almira Kurbegovic; Marie Trudel
Journal:  Hum Mol Genet       Date:  2013-02-25       Impact factor: 6.150

3.  Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.

Authors:  Irma S Lantinga-van Leeuwen; Johannes G Dauwerse; Hans J Baelde; Wouter N Leonhard; Annemieke van de Wal; Christopher J Ward; Sjef Verbeek; Marco C Deruiter; Martijn H Breuning; Emile de Heer; Dorien J M Peters
Journal:  Hum Mol Genet       Date:  2004-10-20       Impact factor: 6.150

4.  Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.

Authors:  R D Gile; B D Cowley; V H Gattone; M P O'Donnell; S K Swan; J J Grantham
Journal:  Am J Kidney Dis       Date:  1995-09       Impact factor: 8.860

Review 5.  Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.

Authors:  Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 10.121

6.  Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.

Authors:  Melissa A Cadnapaphornchai; Diana M George; Kim McFann; Wei Wang; Berenice Gitomer; John D Strain; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

7.  Tolvaptan in patients with autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Arlene B Chapman; Olivier Devuyst; Ron T Gansevoort; Jared J Grantham; Eiji Higashihara; Ronald D Perrone; Holly B Krasa; John Ouyang; Frank S Czerwiec
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

8.  Prospective change in renal volume and function in children with ADPKD.

Authors:  Melissa A Cadnapaphornchai; Kim McFann; John D Strain; Amirali Masoumi; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2009-04       Impact factor: 8.237

9.  Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.

Authors:  Robert Schrier; Kimberly McFann; Ann Johnson; Arlene Chapman; Charles Edelstein; Godela Brosnahan; Tevfik Ecder; Lyn Tison
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

10.  Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension.

Authors:  Melissa A Cadnapaphornchai; Kim McFann; John D Strain; Amirali Masoumi; Robert W Schrier
Journal:  Kidney Int       Date:  2008-08-20       Impact factor: 10.612
  10 in total
  2 in total

Review 1.  Autosomal dominant polycystic kidney disease: updated perspectives.

Authors:  Anjay Rastogi; Khalid Mohammed Ameen; Maha Al-Baghdadi; Kelly Shaffer; Niloofar Nobakht; Mohammad Kamgar; Edgar V Lerma
Journal:  Ther Clin Risk Manag       Date:  2019-08-26       Impact factor: 2.423

Review 2.  Advances in Autosomal Dominant Polycystic Kidney Disease: A Clinical Review.

Authors:  Niloofar Nobakht; Ramy M Hanna; Maha Al-Baghdadi; Khalid Mohammed Ameen; Farid Arman; Ehsan Nobahkt; Mohammad Kamgar; Anjay Rastogi
Journal:  Kidney Med       Date:  2020-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.